Gender difference in the response of growth hormone (GH)-deficient adults to GH therapy

Metabolism: Clinical and Experimental

Volumn 48, Issue 3, 1999, Pages 308-313

  Hayes, Frances J ^a   Fiad, Tarek M ^a   McKenna, T Joseph ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; GROWTH HORMONE; LOW DENSITY LIPOPROTEIN; SOMATOMEDIN C;

ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; CLINICAL ARTICLE; FEMALE; GLUCOSE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HORMONAL THERAPY; HUMAN; HYPOPITUITARISM; MALE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SEX DIFFERENCE;

EID: 0033004725     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90077-X     Document Type: Article

References (41)

1. Salomon F, Cuneo R, Hesp R, et al: The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 321:1797-1803, 1989
2. Jørgensen JOL, Pedersen S, Thuesen L, et al: Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1:1221-1225, 1989
3. Whitehead HM, Boreham C, McIlrath EM, et al: Growth hormone treatment of adults with growth hormone deficiency: Results of a 13-month placebo-controlled cross-over study. Clin Endocrinol (Oxf) 36:45-52, 1992
4. De Boer H, Blok GJ, Van der Veen EA: Clinical aspects of growth hormone deficiency in adults. Endocr Rev 16:63-86, 1995
5. Carroll PV, Christ ER, Bengtsson B-Å, et al: Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review. J Clin Endocrinol Metab 83:382-395, 1998
6. Cuneo RC, Judd S, Wallace JD, et al: The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults. J Clin Endocrinol Metab 83:107-116, 1998
7. McGauley GA: Quality of life assessment before and after growth hormone treatment in hypopituitarism. Acta Paediatr Scand Suppl 356:70-72, 1989
8. Bengtsson B-Å, Eden S, Lönn L, et al: Treatment of adults with growth hormone deficiency with recombinant human growth hormone. J Clin Endocrinol Metab 76:309-317, 1993
9. Burman P, Broman JE, Hetta J, et al: Quality of life in adults with growth hormone (GH) deficiency: Response to treatment with recombinant human GH in a placebo-controlled 21-month trial. J Clin Endocrinol Metab 80:3585-3590, 1995
10. Mårdh G, Lundin K, Borg G, et al: Growth hormone replacement therapy in adult hypopituitary patients with growth hormone deficiency: Combined data from 12 European placebo-controlled trials. Endocrinol Metab 1:43-49,1994 (suppl A)
11. Degerblad M, Almqvist O, Grunditz R, et al: Physical and psychological capabilities during substitution therapy with recombinant growth hormone in adults with growth hormone deficiency. Acta Endocrinol (Copenh) 123:185-193, 1990
12. Russell-Jones DL, Watts GF, Weissberger A, et al: The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients. Clin Endocrinol (Oxf) 41:345-350, 1994
13. Johannsson G, Oscarsson J, Rosen T, et al: Effects of 1 year of growth hormone therapy on serum lipoprotein levels in growth hormone deficient adults. Influence of gender and Apo(a) and Apo(E) phenotypes. Arterioscler Thromb Vasc Biol 15:2142-2150, 1995
14. Garry P, Collins P, Devlin JG: An open 36-month study of lipid changes with growth hormone in adults: Lipid changes following replacement of growth hormone in adult acquired growth hormone deficiency. Eur J Endocrinol 134:61-66, 1996
15. Eden S, Wiklund O, Oscarsson J, et al: Growth hormone treatment of growth hormone deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations. Arterioscler Thromb 13:296-301, 1993
16. Weaver JU, Monson JP, Noonan K, et al: The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity and cardiovascular risk factors in hypopituitary adults. J Clin Endocrinol Metab 80:153-159, 1995
17. Johannsson G, Bjarnason R, Bramnert M, et al: The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age and gender. J Clin Endocrinol Metab 81:1575-1581, 1996
18. Rosén T, Johannsson G, Hallgren P, et al: Beneficial effect of 12 months replacement therapy with recombinant human growth hormone to growth hormone deficient adults. Endocrinol Metab 1:55-66, 1994
19. Christopher M, Hew FL, Oakley M, et al: Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy. J Clin Endocrinol Metab 83:1668-1681, 1998
20. Beshyah SA, Henderson A, Niththyananthan R, et al: The effects of short- and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance. J Clin Endocrinol Metab 80:356-363, 1995
21. Lukaski HC, Johnson PE, Bolonchuk WW, et al: Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 41:810-817, 1985
22. Janssen YJ, Deurenberg P, Roelfsema F, et al: Using dilution techniques and multifrequency bioelectrical impedance to assess both total body water and extracellular water at baseline and during recombinant human growth hormone (GH) treatment in GH-deficient adults. J Clin Endocrinol Metab 82:3349-3355, 1997
23. Hunt SM, McKenna SP, McEwan J, et al: The Nottingham Health Profile subjective health status and medical consultations. Soc Sci Med 15a:221-229, 1981
24. Friedwald WT, Levy RI, Friedricksen DS: Estimation of plasma low density lipoprotein cholesterol concentrations without use of preparative ultracentrifugation. Clin Chem 18:499-512, 1972
25. Hayes FJ, Fiad TM, McKenna TJ: Activity of the renin-angiotensin-aldosterone axis is dependent on the occurrence of edema in growth hormone (GH)-deficient adults treated with GH. J Clin Endocrinol Metab 82:322-323, 1997
26. Shalet SM, Holmes SJ: Growth hormone replacement in adults. BMJ 308:1314-1315, 1994
27. Veldhuis JD: Gender differences in secretory activity of the human somatotropic (growth hormone) axis. Eur J Endocrinol 134:287-295, 1996
28. Janssen YJH, Frolich M, Roelfsema F: A low starting dose of genotropin in growth hormone-deficient adults. J Clin Endocrinol Metab 82:129-135, 1997
29. Lieberman SA, Mitchell AM, Marcus R, et al: The insulin-like growth factor I generation test: Resistance to growth hormone with aging and estrogen replacement. Horm Metab Res 26:229-233, 1994
30. Burman P, Johansson AG, Siegbahn A, et al: Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women. J Clin Endocrinol Metab 82:550-555, 1997
31. Dawson-Hughes B, Stern D, Goldman J, et al: Regulation of growth hormone and somatomedin-C secretion in postmenopausal women: Effect of physiological estrogen replacement. J Clin Endocrinol Metab 63:424-432, 1986
32. Weissberger AJ, Ho KKY, Lazarus L: Contrasting effects of oral and transdermal routes of estrogen replacement on 24 hour growth hormone (GH) secretion, insulin-like growth factor-1, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab 72:374-381, 1991
33. Helle SI, Omsjø IH, Cwyfan Hughes SC, et al: Effects of oral and transdermal estrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: A cross-over study. Clin Endocrinol (Oxf) 45:727-732, 1996
34. Holst J, Cajander S, Carlstrøm K, et al: A comparison of liver protein induction in postmenopausal women during oral and percutaneous estrogen replacement therapy. Br J Obstet Gynaecol 90:355-360, 1983
35. Lignieres BD, Basdevant A, Thomas G, et al: Biologic effects of estradiol-17β in postmenopausal women: Oral versus percutaneous administration. J Clin Endocrinol Metab 62:536-541, 1986
36. Friend KE, Hartman ML, Pezzoli SS, et al: Both oral and transdermal estrogen increase growth hormone release in postmenopausal women - A Clinical Research Study. J Clin Endocrinol Metab 81:2250-2256, 1996
37. Holloway L, Butterfield G, Hintz RL, et al: Effects of recombinant growth hormone on metabolic indices, body composition and bone turnover in healthy, elderly women. J Clin Endocrinol Metab 79:470-479, 1994
38. O'Neal DN, Kalfas A, Dunning PL, et al: The effect of three months of recombinant human growth hormone (rhGH) on insulin and glucose mediated disposal and insulin secretion in GH-deficient adults. J Clin Endocrinol Metab 79:975-983, 1994
39. Johansson JO, Fowelin J, Landin K, et al: Growth hormone-deficient adults are insulin-resistant. Metabolism 44:1126-1129, 1995
40. Hew FL, Koschmann M, Christopher M, et al: Insulin resistance in growth hormone-deficient adults: Defects in glucose utilization and glycogen synthase activity. J Clin Endocrinol Metab 81:555-564, 1996
41. Fowelin J, Attvall S, Lager I, et al: Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metabolism 42:1443-1447, 1993